Global Epilepsy Treatment Devices Market by Product Type (Conventional Devices, Implantable Devices, Wearable Devices), by Technology (Responsive Neurostimulation, Vagus Nerve Stimulator, Accelerometry, Deep Brain Stimulation), by End User (Ambulatory Surgical Centers, Hospitals, Neurology Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Epilepsy Treatment Devices Market research report which is segmented by Product Type (Conventional Devices, Implantable Devices, Wearable Devices), by Technology (Responsive Neurostimulation, Vagus Nerve Stimulator, Accelerometry, Deep Brain Stimulation), by End User (Ambulatory Surgical Centers, Hospitals, Neurology Centers), By Players/Companies NeuroPace Inc., Medtronic Plc., Cerbomed GmbH, Boston Scientific Corporation, electroCore Inc., Cyberonics Inc.”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Epilepsy Treatment Devices Market Research Report |
| By Product Type | Conventional Devices, Implantable Devices, Wearable Devices |
| By Technology | Responsive Neurostimulation, Vagus Nerve Stimulator, Accelerometry, Deep Brain Stimulation |
| By End User | Ambulatory Surgical Centers, Hospitals, Neurology Centers |
| By Companies | NeuroPace Inc., Medtronic Plc., Cerbomed GmbH, Boston Scientific Corporation, electroCore Inc., Cyberonics Inc. |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 217 |
| Number of Tables & Figures | 152 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Epilepsy Treatment Devices Market Report Segments:
The market is segmented by Product Type (Conventional Devices, Implantable Devices, Wearable Devices), by Technology (Responsive Neurostimulation, Vagus Nerve Stimulator, Accelerometry, Deep Brain Stimulation), by End User (Ambulatory Surgical Centers, Hospitals, Neurology Centers).
Some of the companies that are profiled in this report are:
- NeuroPace Inc.
- Medtronic Plc.
- Cerbomed GmbH
- Boston Scientific Corporation
- electroCore Inc.
- Cyberonics Inc.
Epilepsy Treatment Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Epilepsy Treatment Devices Market
Overview of the regional outlook of the Epilepsy Treatment Devices Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Epilepsy Treatment Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Epilepsy Treatment Devices Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Conventional Devices
2. Implantable Devices
3. Wearable Devices
7. By Technology:1. Responsive Neurostimulation
2. Vagus Nerve Stimulator
3. Accelerometry
4. Deep Brain Stimulation
8. By End User:1. Ambulatory Surgical Centers
2. Hospitals
3. Neurology Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epilepsy Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Epilepsy Treatment Devices Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epilepsy Treatment Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Epilepsy Treatment Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Epilepsy Treatment Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Epilepsy Treatment Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Epilepsy Treatment Devices Market Size & Forecast, 2018-2028
4.5.1 Epilepsy Treatment Devices Market Size and Y-o-Y Growth
4.5.2 Epilepsy Treatment Devices Market Absolute $ Opportunity
Chapter 5 Global Epilepsy Treatment Devices Market Analysis and Forecast by Product Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product Type
5.1.2 Basis Point Share (BPS) Analysis by Product Type
5.1.3 Absolute $ Opportunity Assessment by Product Type
5.2 Epilepsy Treatment Devices Market Size Forecast by Product Type
5.2.1 Conventional Devices
5.2.2 Implantable Devices
5.2.3 Wearable Devices
5.3 Market Attractiveness Analysis by Product Type
Chapter 6 Global Epilepsy Treatment Devices Market Analysis and Forecast by Technology
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Technology
6.1.2 Basis Point Share (BPS) Analysis by Technology
6.1.3 Absolute $ Opportunity Assessment by Technology
6.2 Epilepsy Treatment Devices Market Size Forecast by Technology
6.2.1 Responsive Neurostimulation
6.2.2 Vagus Nerve Stimulator
6.2.3 Accelerometry
6.2.4 Deep Brain Stimulation
6.3 Market Attractiveness Analysis by Technology
Chapter 7 Global Epilepsy Treatment Devices Market Analysis and Forecast by End User
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End User
7.1.2 Basis Point Share (BPS) Analysis by End User
7.1.3 Absolute $ Opportunity Assessment by End User
7.2 Epilepsy Treatment Devices Market Size Forecast by End User
7.2.1 Ambulatory Surgical Centers
7.2.2 Hospitals
7.2.3 Neurology Centers
7.3 Market Attractiveness Analysis by End User
Chapter 8 Global Epilepsy Treatment Devices Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Epilepsy Treatment Devices Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Epilepsy Treatment Devices Analysis and Forecast
10.1 Introduction
10.2 North America Epilepsy Treatment Devices Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Epilepsy Treatment Devices Market Size Forecast by Product Type
10.6.1 Conventional Devices
10.6.2 Implantable Devices
10.6.3 Wearable Devices
10.7 Basis Point Share (BPS) Analysis by Product Type
10.8 Absolute $ Opportunity Assessment by Product Type
10.9 Market Attractiveness Analysis by Product Type
10.10 North America Epilepsy Treatment Devices Market Size Forecast by Technology
10.10.1 Responsive Neurostimulation
10.10.2 Vagus Nerve Stimulator
10.10.3 Accelerometry
10.10.4 Deep Brain Stimulation
10.11 Basis Point Share (BPS) Analysis by Technology
10.12 Absolute $ Opportunity Assessment by Technology
10.13 Market Attractiveness Analysis by Technology
10.14 North America Epilepsy Treatment Devices Market Size Forecast by End User
10.14.1 Ambulatory Surgical Centers
10.14.2 Hospitals
10.14.3 Neurology Centers
10.15 Basis Point Share (BPS) Analysis by End User
10.16 Absolute $ Opportunity Assessment by End User
10.17 Market Attractiveness Analysis by End User
Chapter 11 Europe Epilepsy Treatment Devices Analysis and Forecast
11.1 Introduction
11.2 Europe Epilepsy Treatment Devices Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Epilepsy Treatment Devices Market Size Forecast by Product Type
11.6.1 Conventional Devices
11.6.2 Implantable Devices
11.6.3 Wearable Devices
11.7 Basis Point Share (BPS) Analysis by Product Type
11.8 Absolute $ Opportunity Assessment by Product Type
11.9 Market Attractiveness Analysis by Product Type
11.10 Europe Epilepsy Treatment Devices Market Size Forecast by Technology
11.10.1 Responsive Neurostimulation
11.10.2 Vagus Nerve Stimulator
11.10.3 Accelerometry
11.10.4 Deep Brain Stimulation
11.11 Basis Point Share (BPS) Analysis by Technology
11.12 Absolute $ Opportunity Assessment by Technology
11.13 Market Attractiveness Analysis by Technology
11.14 Europe Epilepsy Treatment Devices Market Size Forecast by End User
11.14.1 Ambulatory Surgical Centers
11.14.2 Hospitals
11.14.3 Neurology Centers
11.15 Basis Point Share (BPS) Analysis by End User
11.16 Absolute $ Opportunity Assessment by End User
11.17 Market Attractiveness Analysis by End User
Chapter 12 Asia Pacific Epilepsy Treatment Devices Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by Product Type
12.6.1 Conventional Devices
12.6.2 Implantable Devices
12.6.3 Wearable Devices
12.7 Basis Point Share (BPS) Analysis by Product Type
12.8 Absolute $ Opportunity Assessment by Product Type
12.9 Market Attractiveness Analysis by Product Type
12.10 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by Technology
12.10.1 Responsive Neurostimulation
12.10.2 Vagus Nerve Stimulator
12.10.3 Accelerometry
12.10.4 Deep Brain Stimulation
12.11 Basis Point Share (BPS) Analysis by Technology
12.12 Absolute $ Opportunity Assessment by Technology
12.13 Market Attractiveness Analysis by Technology
12.14 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by End User
12.14.1 Ambulatory Surgical Centers
12.14.2 Hospitals
12.14.3 Neurology Centers
12.15 Basis Point Share (BPS) Analysis by End User
12.16 Absolute $ Opportunity Assessment by End User
12.17 Market Attractiveness Analysis by End User
Chapter 13 Latin America Epilepsy Treatment Devices Analysis and Forecast
13.1 Introduction
13.2 Latin America Epilepsy Treatment Devices Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Epilepsy Treatment Devices Market Size Forecast by Product Type
13.6.1 Conventional Devices
13.6.2 Implantable Devices
13.6.3 Wearable Devices
13.7 Basis Point Share (BPS) Analysis by Product Type
13.8 Absolute $ Opportunity Assessment by Product Type
13.9 Market Attractiveness Analysis by Product Type
13.10 Latin America Epilepsy Treatment Devices Market Size Forecast by Technology
13.10.1 Responsive Neurostimulation
13.10.2 Vagus Nerve Stimulator
13.10.3 Accelerometry
13.10.4 Deep Brain Stimulation
13.11 Basis Point Share (BPS) Analysis by Technology
13.12 Absolute $ Opportunity Assessment by Technology
13.13 Market Attractiveness Analysis by Technology
13.14 Latin America Epilepsy Treatment Devices Market Size Forecast by End User
13.14.1 Ambulatory Surgical Centers
13.14.2 Hospitals
13.14.3 Neurology Centers
13.15 Basis Point Share (BPS) Analysis by End User
13.16 Absolute $ Opportunity Assessment by End User
13.17 Market Attractiveness Analysis by End User
Chapter 14 Middle East & Africa (MEA) Epilepsy Treatment Devices Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by Product Type
14.6.1 Conventional Devices
14.6.2 Implantable Devices
14.6.3 Wearable Devices
14.7 Basis Point Share (BPS) Analysis by Product Type
14.8 Absolute $ Opportunity Assessment by Product Type
14.9 Market Attractiveness Analysis by Product Type
14.10 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by Technology
14.10.1 Responsive Neurostimulation
14.10.2 Vagus Nerve Stimulator
14.10.3 Accelerometry
14.10.4 Deep Brain Stimulation
14.11 Basis Point Share (BPS) Analysis by Technology
14.12 Absolute $ Opportunity Assessment by Technology
14.13 Market Attractiveness Analysis by Technology
14.14 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by End User
14.14.1 Ambulatory Surgical Centers
14.14.2 Hospitals
14.14.3 Neurology Centers
14.15 Basis Point Share (BPS) Analysis by End User
14.16 Absolute $ Opportunity Assessment by End User
14.17 Market Attractiveness Analysis by End User
Chapter 15 Competition Landscape
15.1 Epilepsy Treatment Devices Market: Competitive Dashboard
15.2 Global Epilepsy Treatment Devices Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 NeuroPace Inc.
15.3.2 Medtronic Plc.
15.3.3 Cerbomed GmbH
15.3.4 Boston Scientific Corporation
15.3.5 electroCore Inc.
15.3.6 Cyberonics Inc.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epilepsy Treatment Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Epilepsy Treatment Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Epilepsy Treatment Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Epilepsy Treatment Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Epilepsy Treatment Devices Market Size & Forecast, 2018-2028
4.5.1 Epilepsy Treatment Devices Market Size and Y-o-Y Growth
4.5.2 Epilepsy Treatment Devices Market Absolute $ Opportunity
Chapter 5 Global Epilepsy Treatment Devices Market Analysis and Forecast by Product Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product Type
5.1.2 Basis Point Share (BPS) Analysis by Product Type
5.1.3 Absolute $ Opportunity Assessment by Product Type
5.2 Epilepsy Treatment Devices Market Size Forecast by Product Type
5.2.1 Conventional Devices
5.2.2 Implantable Devices
5.2.3 Wearable Devices
5.3 Market Attractiveness Analysis by Product Type
Chapter 6 Global Epilepsy Treatment Devices Market Analysis and Forecast by Technology
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Technology
6.1.2 Basis Point Share (BPS) Analysis by Technology
6.1.3 Absolute $ Opportunity Assessment by Technology
6.2 Epilepsy Treatment Devices Market Size Forecast by Technology
6.2.1 Responsive Neurostimulation
6.2.2 Vagus Nerve Stimulator
6.2.3 Accelerometry
6.2.4 Deep Brain Stimulation
6.3 Market Attractiveness Analysis by Technology
Chapter 7 Global Epilepsy Treatment Devices Market Analysis and Forecast by End User
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End User
7.1.2 Basis Point Share (BPS) Analysis by End User
7.1.3 Absolute $ Opportunity Assessment by End User
7.2 Epilepsy Treatment Devices Market Size Forecast by End User
7.2.1 Ambulatory Surgical Centers
7.2.2 Hospitals
7.2.3 Neurology Centers
7.3 Market Attractiveness Analysis by End User
Chapter 8 Global Epilepsy Treatment Devices Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Epilepsy Treatment Devices Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Epilepsy Treatment Devices Analysis and Forecast
10.1 Introduction
10.2 North America Epilepsy Treatment Devices Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Epilepsy Treatment Devices Market Size Forecast by Product Type
10.6.1 Conventional Devices
10.6.2 Implantable Devices
10.6.3 Wearable Devices
10.7 Basis Point Share (BPS) Analysis by Product Type
10.8 Absolute $ Opportunity Assessment by Product Type
10.9 Market Attractiveness Analysis by Product Type
10.10 North America Epilepsy Treatment Devices Market Size Forecast by Technology
10.10.1 Responsive Neurostimulation
10.10.2 Vagus Nerve Stimulator
10.10.3 Accelerometry
10.10.4 Deep Brain Stimulation
10.11 Basis Point Share (BPS) Analysis by Technology
10.12 Absolute $ Opportunity Assessment by Technology
10.13 Market Attractiveness Analysis by Technology
10.14 North America Epilepsy Treatment Devices Market Size Forecast by End User
10.14.1 Ambulatory Surgical Centers
10.14.2 Hospitals
10.14.3 Neurology Centers
10.15 Basis Point Share (BPS) Analysis by End User
10.16 Absolute $ Opportunity Assessment by End User
10.17 Market Attractiveness Analysis by End User
Chapter 11 Europe Epilepsy Treatment Devices Analysis and Forecast
11.1 Introduction
11.2 Europe Epilepsy Treatment Devices Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Epilepsy Treatment Devices Market Size Forecast by Product Type
11.6.1 Conventional Devices
11.6.2 Implantable Devices
11.6.3 Wearable Devices
11.7 Basis Point Share (BPS) Analysis by Product Type
11.8 Absolute $ Opportunity Assessment by Product Type
11.9 Market Attractiveness Analysis by Product Type
11.10 Europe Epilepsy Treatment Devices Market Size Forecast by Technology
11.10.1 Responsive Neurostimulation
11.10.2 Vagus Nerve Stimulator
11.10.3 Accelerometry
11.10.4 Deep Brain Stimulation
11.11 Basis Point Share (BPS) Analysis by Technology
11.12 Absolute $ Opportunity Assessment by Technology
11.13 Market Attractiveness Analysis by Technology
11.14 Europe Epilepsy Treatment Devices Market Size Forecast by End User
11.14.1 Ambulatory Surgical Centers
11.14.2 Hospitals
11.14.3 Neurology Centers
11.15 Basis Point Share (BPS) Analysis by End User
11.16 Absolute $ Opportunity Assessment by End User
11.17 Market Attractiveness Analysis by End User
Chapter 12 Asia Pacific Epilepsy Treatment Devices Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by Product Type
12.6.1 Conventional Devices
12.6.2 Implantable Devices
12.6.3 Wearable Devices
12.7 Basis Point Share (BPS) Analysis by Product Type
12.8 Absolute $ Opportunity Assessment by Product Type
12.9 Market Attractiveness Analysis by Product Type
12.10 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by Technology
12.10.1 Responsive Neurostimulation
12.10.2 Vagus Nerve Stimulator
12.10.3 Accelerometry
12.10.4 Deep Brain Stimulation
12.11 Basis Point Share (BPS) Analysis by Technology
12.12 Absolute $ Opportunity Assessment by Technology
12.13 Market Attractiveness Analysis by Technology
12.14 Asia Pacific Epilepsy Treatment Devices Market Size Forecast by End User
12.14.1 Ambulatory Surgical Centers
12.14.2 Hospitals
12.14.3 Neurology Centers
12.15 Basis Point Share (BPS) Analysis by End User
12.16 Absolute $ Opportunity Assessment by End User
12.17 Market Attractiveness Analysis by End User
Chapter 13 Latin America Epilepsy Treatment Devices Analysis and Forecast
13.1 Introduction
13.2 Latin America Epilepsy Treatment Devices Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Epilepsy Treatment Devices Market Size Forecast by Product Type
13.6.1 Conventional Devices
13.6.2 Implantable Devices
13.6.3 Wearable Devices
13.7 Basis Point Share (BPS) Analysis by Product Type
13.8 Absolute $ Opportunity Assessment by Product Type
13.9 Market Attractiveness Analysis by Product Type
13.10 Latin America Epilepsy Treatment Devices Market Size Forecast by Technology
13.10.1 Responsive Neurostimulation
13.10.2 Vagus Nerve Stimulator
13.10.3 Accelerometry
13.10.4 Deep Brain Stimulation
13.11 Basis Point Share (BPS) Analysis by Technology
13.12 Absolute $ Opportunity Assessment by Technology
13.13 Market Attractiveness Analysis by Technology
13.14 Latin America Epilepsy Treatment Devices Market Size Forecast by End User
13.14.1 Ambulatory Surgical Centers
13.14.2 Hospitals
13.14.3 Neurology Centers
13.15 Basis Point Share (BPS) Analysis by End User
13.16 Absolute $ Opportunity Assessment by End User
13.17 Market Attractiveness Analysis by End User
Chapter 14 Middle East & Africa (MEA) Epilepsy Treatment Devices Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by Product Type
14.6.1 Conventional Devices
14.6.2 Implantable Devices
14.6.3 Wearable Devices
14.7 Basis Point Share (BPS) Analysis by Product Type
14.8 Absolute $ Opportunity Assessment by Product Type
14.9 Market Attractiveness Analysis by Product Type
14.10 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by Technology
14.10.1 Responsive Neurostimulation
14.10.2 Vagus Nerve Stimulator
14.10.3 Accelerometry
14.10.4 Deep Brain Stimulation
14.11 Basis Point Share (BPS) Analysis by Technology
14.12 Absolute $ Opportunity Assessment by Technology
14.13 Market Attractiveness Analysis by Technology
14.14 Middle East & Africa (MEA) Epilepsy Treatment Devices Market Size Forecast by End User
14.14.1 Ambulatory Surgical Centers
14.14.2 Hospitals
14.14.3 Neurology Centers
14.15 Basis Point Share (BPS) Analysis by End User
14.16 Absolute $ Opportunity Assessment by End User
14.17 Market Attractiveness Analysis by End User
Chapter 15 Competition Landscape
15.1 Epilepsy Treatment Devices Market: Competitive Dashboard
15.2 Global Epilepsy Treatment Devices Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 NeuroPace Inc.
15.3.2 Medtronic Plc.
15.3.3 Cerbomed GmbH
15.3.4 Boston Scientific Corporation
15.3.5 electroCore Inc.
15.3.6 Cyberonics Inc.
Segments Covered in the Report
The global Epilepsy Treatment Devices market has been segmented based on
By Product Type
The global Epilepsy Treatment Devices market has been segmented based on
By Product Type
- Conventional Devices
- Implantable Devices
- Wearable Devices
- Responsive Neurostimulation
- Vagus Nerve Stimulator
- Accelerometry
- Deep Brain Stimulation
- Ambulatory Surgical Centers
- Hospitals
- Neurology Centers
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- NeuroPace Inc.
- Medtronic Plc.
- Cerbomed GmbH
- Boston Scientific Corporation
- electroCore Inc.
- Cyberonics Inc.
Our Clients
Related Reports
Some other reports from this category!
